Palomino Laboratories reported total assets of $8.43M and total liabilities of $0.34M for the quarter ended Dec 2025. This balance sheet covers 11 quarters of results from Dec 2022 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2022 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash & EquivalentsCash & Equiv. | 500.00 | 380.00 | 380.00 | 380.00 | 322.00 | 322.00 | 0.13M | 0.25M | 0.00M | 7.90M | 8.12M |
| Cash & Current Investments | 500.00 | 380.00 | 380.00 | 380.00 | 322.00 | 322.00 | 0.13M | 0.25M | 0.00M | 7.90M | 8.12M |
| Prepaid Assets | 0.00M | 0.42M | 0.31M | ||||||||
| Current Assets | 500.00 | 380.00 | 380.00 | 380.00 | 322.00 | 322.00 | 0.03M | 0.02M | 0.00M | 8.43M | |
| Non-Current Assets | |||||||||||
| Long-Term Deferred Tax | 0.01M | 0.73M | |||||||||
| Non-Current Assets | 0.11M | ||||||||||
| Assets | 500.00 | 380.00 | 380.00 | 380.00 | 322.00 | 322.00 | 0.14M | 0.02M | 0.00M | 8.31M | 8.43M |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payables | 0.01M | 0.03M | 58.00 | 0.05M | 0.04M | 0.05M | 0.00M | 0.05M | 0.04M | 0.06M | 0.06M |
| Notes Payables | 304.00 | 0.02M | 0.08M | 0.08M | 0.11M | 0.13M | 0.28M | 0.28M | 0.02M | 0.32M | |
| Payables | 0.01M | 0.05M | 0.08M | 0.13M | 0.15M | 0.18M | 0.28M | 0.32M | 0.06M | 0.38M | 0.06M |
| Accumulated Expenses | 0.59M | 0.28M | |||||||||
| Other Accumulated Expenses | 0.01M | 0.03M | 0.04M | 0.04M | 0.04M | 0.00M | 0.00M | 0.01M | 0.00M | ||
| Total Current Liabilities | 0.03M | 0.08M | 0.11M | 0.16M | 0.19M | 0.22M | 0.01M | 0.34M | 0.36M | 1.00M | 0.34M |
| Non-Current Liabilities | |||||||||||
| Non-Current Debt | 0.01M | 0.02M | 0.01M | 0.01M | 0.03M | 0.03M | |||||
| Other Non-Current Liabilities | 0.15M | 0.01M | |||||||||
| Total Non-Current Liabilities | 0.01M | 0.32M | |||||||||
| Total Liabilities | 0.03M | 0.08M | 0.11M | 0.16M | 0.19M | 0.22M | 0.16M | 0.34M | 0.36M | 1.00M | 0.34M |
| Shareholder's Equity | |||||||||||
| Total Debt | 0.01M | 0.04M | 0.09M | 0.09M | 0.14M | 0.16M | 0.28M | 0.28M | 0.02M | 0.32M | |
| Common Equity | -0.03M | -0.08M | -0.02M | -0.00M | -0.00M | -0.01M | -0.02M | -0.99M | -0.45M | 7.31M | 8.10M |
| Liabilities and Shareholders Equity | 500.00 | 380.00 | 380.00 | 380.00 | 322.00 | 322.00 | 0.14M | 0.02M | 0.00M | 8.31M | 8.43M |
| Retained Earnings | -0.03M | -0.08M | -0.11M | -0.16M | -0.19M | -0.22M | -0.02M | -0.32M | -0.36M | 9.75M | 11.28M |
| Preferred Shares | 10.00M | 10.00M |